In AVAC Report 2014/15: HIV Prevention on the Line, we take on the current state of global targets for the AIDS response, looking beyond pithy slogans to explore what’s in place and what’s not in terms of targets, resources and action to begin to end the AIDS epidemic. We also provide concise updates and calls to action on key prevention interventions including AIDS vaccines, voluntary medical male circumcision, microbicides, PrEP, and hormonal contraception use and HIV risk.
AVAC Report 2014/15: HIV Prevention on the Line
Intervention Update: Hormonal Contraception and HIV
Excerpted from AVAC Report: HIV Prevention on the Line, this update describes recent discussion and analysis in the search for answers as to whether hormonal contraceptives, including long-acting methods such as Depo-Provera (DPMA) and other injectable contraceptives and the implant, affect women’s risk of acquiring HIV.
Intervention Update: Voluntary Medical Male Circumcision
Excerpted from AVAC Report: HIV Prevention on the Line, this update cites the success of a previous VMMC target and suggests the current lack of a target moving forward will stifle continued progress.
Intervention Update: What’s Next for AIDS Vaccines and the P5 Partnership?
Excerpted from AVAC Report: HIV Prevention on the Line, this update details attempts to test vaccine strategy which showed promise in the RV144 trial.
What’s Next for the Pox-Protein Public-Private Partnership (P5)?
This timeline, appearing in AVAC Report 2014/2015: HIV Prevention on the Line, shows the progress and future of the P5.
Mind the Gap
This graphic, presented in the AVAC Report 2014/15: HIV Prevention on the Line, shows all the components of a comprehensive response to end the epidemic.
Global ART Coverage (2014)
This graphic, which appears in the AVAC Report 2014/15: HIV Prevention on the Line, depicts global ART coverage.
What to Expect for PrEP in Africa in 2015
Appearing in the AVAC Report 2014/15: HIV Prevention on the Line, this graphic shows ongoing and completed PrEP trials in Africa.
Global HIV Prevention R&D Investment 2009-2013
Appearing in AVAC Report 2014/15: HIV Prevention on the Line, this graphic shows the global HIV prevention research and development investment from 2009-2013.
Px Wire January-March 2015, Vol. 8, No. 1
Px Wire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. This issue includes a highly selective list of ten issues, events and developments to hold attention and spark actions in 2015—and beyond. This issue is also available as a webpage.